Skip to main content
メニュー
Revvity logo
Contact us
JP
Revvity Sites Globally

Select your location.

*e-commerce not available for this region.

australia.webp Australia
austria.webp Austria
belgium.webp Belgium
brazil.webp Brazil *
canada.webp Canada
china.webp China *
denmark.webp Denmark
finland.webp Finland
france.webp France
germany.webp Germany
hong-kong.webp Hong Kong (China) *
india.webp India *
ireland.webp Ireland
italy.webp Italy
japan.webp Japan *
luxembourg.webp Luxembourg
mexico.webp Mexico *
netherlands.webp Netherlands
norway.webp Norway
philippines.webp Philippines *
republic of korea.webp Republic of Korea *
singapore.webp Singapore *
spain.webp Spain
sweden.webp Sweden
switzerland.webp Switzerland
thailand.webp Thailand *
uk.webp United Kingdom
usa.webp United States
Breadcrumb
...
  • ホーム
  • World Tuberculosis Day 2025: Commit, Invest, Deliver to End TB

World Tuberculosis Day 2025

Commit, Invest, Deliver to End TB

As we mark World Tuberculosis Day on 24 March 2025 we're faced with a stark reality: tuberculosis (TB) has reclaimed its position as the world's leading infectious disease killer. With 10.8 million new cases and 1.25 million deaths in 2023, the fight against TB is far from over1. This year's theme, "Yes! We Can End TB: Commit, Invest, Deliver," calls for urgent action and accountability in our global efforts to eliminate this preventable and curable disease.

At Revvity, we're committed to this fight through innovative diagnostics for latent TB infection (LTBI). With nearly a quarter of the global population estimated to be living with TB infection, early detection is crucial. As we strive to meet the WHO's End TB Strategy goals, including an 80% reduction in new cases by 20302, accurate diagnostics are more crucial than ever in breaking the cycle of transmission and enabling targeted prevention and treatment.

For World TB Day, explore our comprehensive resources on the global TB landscape, including our detailed blog post on the latest WHO Global Tuberculosis Report and our informative infographic highlighting key statistics and challenges. By raising awareness and inspiring action, we can collectively turn the tide on TB and work towards a healthier, TB-free future for all.

img-header-l4-world-tuberculosis-day-2025.jpg
  • Quick links
  • Download infographic | Watch webinar | Read blog
  • Watch patient stories
  • Hear from our experts

Explore our resources on the global TB landscape

img-tb-landing-page-Infographic-512x288.png

Infographic

Uncover the Global TB Landscape

Join the fight against TB! Explore the challenging global TB landscape and the critical role of diagnostic testing in treatment, prevention and elimination.

Download infographic
img-tb-landing-page-webinar-512x288.jpg

Webinar

Improving the management of latent TB infection

Listen to Dr. Jonathan Hoffman, Tuberculosis Research Manager at Fondation Mérieux on Improving the management of latent TB infection in Cameroon and Madagascar.

Watch webinar
img-blog-feature-tile-on-tb-landing-page-512x288.png

Blog

Raising awareness to support global TB control efforts.

World TB Day 2025: Exploring global trends, innovative diagnostics, and the path to ending tuberculosis.

Read blog

Watch TB patient stories

As we commemorate World Tuberculosis Day 2025 under the theme "Yes! We Can End TB: Commit, Invest, Deliver," it's crucial to remember that behind every statistic is a human story. The fight against TB is not just about numbers; it's about people - their struggles, resilience, and triumphs.

To bring this reality to life, we're honored to share three powerful patient stories that embody the spirit of this year's theme. These individuals - Kelly, Taylor, and Khayr - have not only battled TB but have also committed themselves to educating others, invested their time and energy in advocacy, and continue to deliver hope to those affected by this disease.

Their experiences highlight the importance of early detection, proper treatment, and community support in overcoming TB. As you watch these videos, consider how each story reflects the urgent need for global commitment, investment, and action in our collective efforts to end TB. Let their stories inspire us all to redouble our efforts in the mission to create a TB-free world.

img-kelly-feature-tile-512x288.png

Kelly

Kelly is a physician and has treated patients with TB. Being a TB patient, however, was new territory for him. One of the most difficult parts of the process was the impact on his family, friends and patients, who were forced to endure months of treatment due to their contact with him. He now brings a new understanding to his practice and works tirelessly to educate others, especially those in the healthcare community.

img-taylor-feature-tile-512x288.png

Taylor

Taylor is a community health worker. Originally from the Philippines, Taylor had latent tuberculosis (LTBI) and then contracted HIV. This caused her LTBI to become active, and she became very sick. After undergoing many months of treatment, Taylor recovered from TB and now works to educate others, particularly those in the LGBTQ community.

img-kahyr-feature-tile-512x288.png

Kahyr  

Khayr is a North Dakota resident and a successful hotel manager. He spent time living in Somalia as a college student, where he likely contracted multidrug-resistant (MDR) TB. Khayr was told that his chance of survival was 50%. After a long battle, he recovered and now works with We are TB, the survivor advocacy organization.

Hear from our experts

For World TB Day, we asked our experts: 'what's the most impactful action we can take today to accelerate the end of TB?'

img-tb-landing-page-dr-ali-512x288.png

"To accelerate the end of TB, we must focus on immediate case identification and treatment, robust contact screening, enhance detection of latent tuberculosis infection through specific advanced diagnostic tools. especially in high-risk and immunocompromised populations. With this multi-prong approach, we can break the cycle of TB transmission and move closer to global TB elimination"

Juzar Ali
MD, Professor (Emeritus) of Medicine at Louisiana State University Health Sciences Center

img-tb-landing-page-dr-obermeier-512x288.png

"The biggest challenge is convincing healthcare providers of the necessity of testing. Especially in patients with HIV or under immunosuppressive therapy, who are at high risk of developing active TB, early detection is key: If you can diagnose and treat LTBI before progressing into active disease, it's much easier, especially if you're comparing it to treating extensively drug-resistant tuberculosis. Early detection and intervention are key to preventing active TB disease and ultimately accelerate the end of TB."

Dr Martin Obermeier
Lab Manager at the Medical Centre for Infectious Diseases in Berlin (MIB)

img-tb-landing-page-dr-juliani-512x288.png

"TB is widespread in our country, affecting both urban and rural areas. Early detection of all forms of TB is crucial for controlling its spread. Identifying latent TB is essential, as many are unaware, they have it. Diagnosing extra-pulmonary TB, often missed by conventional methods, is critical. We've seen many unexpected cases linked to it. Comorbidities like diabetes or HIV complicate TB cases and require immediate identification. This World TB Day, I hope decision-makers will prioritize early detection and broader use of diagnostic tools to help end TB."

Dr Juliani Dewi, SpPK
Clinical Pathologist Lab Director, Rampal Diagnostika, Indonesia

References

  1. Global tuberculosis report 2024. Geneva: World Health Organization; 2023. Licence: CC BY-NC-SA 3.0 IGO.
  2. World Health Organization. The End TB Strategy. Geneva; 2014. https://www.who.int/teams/global-tuberculosisprogramme/theend-tb-strategy. Accessed: 2-AUG-23

Products may not be licensed in accordance with the laws in all countries. Please check with your local representative for availability, Revvity, Inc. does not endorse or make recommendations with respect to research, medication, or treatments. All information presented is for informational purposes only and is not intended as medical advice.

Revvity Logo

©2025 Revvity - All rights reserved

Revvity is a trademark of Revvity, Inc. All other trademarks are the property of their respective owners.